Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Minimaze procedure Stories

2010-05-13 06:30:00

RALEIGH, N.C., May 13 /PRNewswire/ -- nContact Surgical, Inc. (nContact) announced it has enrolled the first patient in its IDE trials to evaluate a fully closed chest procedure combining the best of Electrophysiologist (EP) catheter and surgical techniques for the treatment of atrial fibrillation (AF) using the investigational Numeris® - AF Guided Coagulation System with VisiTrax®. The three hour procedure is performed in a single setting, generally...

2010-04-19 07:30:00

MORRISVILLE, N.C., April 19 /PRNewswire/ -- nContact Surgical, Inc ("nContact") today announced it has received the first Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to evaluate the safety and efficacy of a combined surgical and catheter procedure (the convergent procedure) to treat patients with longstanding persistent atrial fibrillation (AF). nContact's Numeris®-AF Guided Coagulation System with VisiTrax®...

2009-12-01 07:41:00

MORRISVILLE, N.C., Dec. 1 /PRNewswire/ -- nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, today announced the initiation of a feasibility clinical trial designed to evaluate the safety and efficacy of a combined surgical and catheter procedure, the convergent procedure, for the treatment of symptomatic paroxysmal atrial fibrillation (AF). This prospective, feasibility study will enroll patients at study...

2009-11-19 09:55:00

MORRISVILLE, N.C., Nov. 19 /PRNewswire/ -- nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for minimally-invasive treatment for heart conditions, announced that data from a poster was presented at the American Heart Association Scientific Sessions in Orlando. The study demonstrated that the convergent approach, which combines surgical and electrophysiological expertise, appears to be a good strategy to achieve short term success in patients with long standing...

2009-11-16 07:31:00

MORRISVILLE, N.C., Nov. 16 /PRNewswire/ -- nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for non-invasive treatment for heart conditions, today announced the initiation of a clinical trial designed to evaluate the safety and efficacy of its Numeris® - AF Tethered Coagulation System with VisiTrax® device in an open-chest concomitant procedure for the treatment of longstanding persistent atrial fibrillation (AF). This...

f34a6c43c09c651d12855a13d308f4a5
2009-11-05 07:47:56

Animal Study Findings Could Point to More Precise Treatments for Atrial Fibrillation While studying how the heart is formed, scientists at the University of Pennsylvania School of Medicine serendipitously found a novel cellular source of atrial fibrillation (AF), the most common type of abnormal heart beat. Jonathan Epstein, MD, William Wikoff Smith Professor, and Chair, Department of Cell and Developmental Biology, and Vickas Patel,   MD, PhD, Assistant Professor of Medicine, ...

2009-07-08 13:30:00

WAUSAU, Wis., July 8 /PRNewswire/ -- Like an estimated 5 million other Americans, Barry Simonis had atrial fibrillation, a common heart condition that greatly increases the risk of stroke and causes the most important muscle in our bodies to beat irregularly. Aspirus cardiovascular surgeon John Johnkoski, M.D., recently performed an advanced surgical procedure called thoracoscopic ablation on Simonis to correct the condition that plagued the Rosholt resident for more than 10 years. During...

2008-10-31 18:00:39

AtriCure, Inc. (Nasdaq: ATRC), received a letter on October 27, 2008 from the U.S. Department of Justice-Civil Division (the "DOJ") informing the Company that the DOJ is conducting an investigation for potential False Claims Act and common law violations relating to the Company's surgical ablation devices. Specifically, the letter states that the DOJ is investigating the Company's marketing practices utilized in connection with its surgical ablation system to treat atrial fibrillation, a...

2008-10-27 09:00:41

Cardima, Inc. (OTCBB: CADM), a medical device company focused on the treatment of Atrial Fibrillation ("AF") and manufacturer of the Cardima Surgical Ablation System, the EP Ablation System, and the PATHFINDER(R) family of diagnostic microcatheters, is pleased to announce the establishment of its Surgical Ablation Training Program and Center of Excellence at Stamford Hospital, Stamford, Connecticut, for the Cardima Surgical Ablation System. Stamford Hospital is an internationally recognized...

2008-09-02 09:00:42

DALLAS, Sept. 2 /PRNewswire/ -- StopAfib.org, at http://www.stopafib.org/, announces that September is Atrial Fibrillation Month to raise awareness of this life-threatening irregular heartbeat, commonly called afib or AF. Once considered benign, this common cardiac arrhythmia can often lead to congestive heart failure or stroke. Every five minutes, someone in the U.S. has a stroke caused by AF. Stroke is our #3 killer and the #1 cause of permanent disability, and takes a disproportionate...